A - Human Necessities – 01 – N
Patent
A - Human Necessities
01
N
A01N 43/56 (2006.01) A61K 31/00 (2006.01) A61K 31/415 (2006.01)
Patent
CA 2318778
Angiotensin II receptor antagonists are useful for decreasing QT dispersion or inhibiting the progression of QT prolongation in patients. Also disclosed is a method for monitoring the reduction in the risk of experiencing an adverse cardiac event, such as sudden cardiac death, myocardial infarction or arrhythmias, using QT dispersion in patients treated with a therapeutically effective amount of an angiotensin II antagonist.
Antagonistes de récepteur de l'angiotensine II qui sont utiles pour réduire l'allongement de l'espace QT ou inhiber la progression de l'allongement de l'espace QT chez des patients. Un procédé de surveillance de la réduction du risque de problème cardiaque tel que la mort cardiaque subite, l'infarctus du myocarde ou les arythmies sur la base de l'allongement de l'espace QT chez des patients traités avec une quantité thérapeutiquement efficace d'un antagoniste d'angiotensine II sont également décrits.
Deckelbaum Lawrence I.
Robinson Paul J.
Segal Robert
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Method for decreasing qt dispersion or inhibiting the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for decreasing qt dispersion or inhibiting the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for decreasing qt dispersion or inhibiting the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1395157